Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NEPH

Nephros

$0.00

(0.00%)

, GIGL

Giggles N' Hugs

$0.00

(0.00%)

07:22
05/08/18
05/08
07:22
05/08/18
07:22
Conference/Events
Reed Smith to hold a conference »

2018 Disruptive Growth…

NEPH

Nephros

$0.00

(0.00%)

GIGL

Giggles N' Hugs

$0.00

(0.00%)

CLSN

Celsion

$2.40

0.05 (2.13%)

ORMP

Oramed

$6.47

-0.19 (-2.85%)

REED

Reed's

$2.15

(0.00%)

MBII

Marrone Bio

$1.73

0.02 (1.17%)

ITUS

ITUS

$3.71

-0.02 (-0.54%)

BURG

Chanticleer Holdings

$3.42

0.03 (0.88%)

VNRX

VolitionRx

$2.26

0.04 (1.80%)

NAVB

Navidea

$0.27

0.0051 (1.93%)

ISR

IsoRay

$0.42

-0.015 (-3.45%)

GNPX

Genprex

$13.70

-0.61 (-4.26%)

DCTH

Delcath Systems

$0.00

(0.00%)

MLSS

Milestone Scientific

$0.73

-0.0099 (-1.34%)

CVM

CEL-SCI

$2.74

0.41 (17.60%)

NURO

NeuroMetrix

$1.37

-0.03 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 08

    May

  • 09

    May

  • 10

    May

  • 11

    May

  • 11

    May

  • 14

    May

ITUS

ITUS

$4.05

-0.31 (-7.11%)

, RCUS

Arcus Biosciences

$17.00

0.33 (1.98%)

04:55
04/18/18
04/18
04:55
04/18/18
04:55
Conference/Events
American Association for Cancer Research to hold annual meeting »

AACR Annual Meeting 2018…

ITUS

ITUS

$4.05

-0.31 (-7.11%)

RCUS

Arcus Biosciences

$17.00

0.33 (1.98%)

FATE

Fate Therapeutics

$11.53

0.36 (3.22%)

CRSP

Crispr Therapeutics

$52.75

1.73 (3.39%)

ABBV

AbbVie

$93.57

0.99 (1.07%)

ADAP

Adaptimmune

$12.33

-0.03 (-0.24%)

AMGN

Amgen

$174.95

3.58 (2.09%)

AZN

AstraZeneca

$35.85

0.105 (0.29%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$52.36

-1.72 (-3.18%)

CYAD

Celyad

$31.00

-0.5 (-1.59%)

ECYT

Endocyte

$10.05

0.81 (8.77%)

MRK

Merck

$59.29

0.63 (1.07%)

AGLE

Aeglea BioTherapeutics

$9.40

0.35 (3.87%)

SYRS

Syros Pharmaceuticals

$13.50

0.35 (2.66%)

CRL

Charles River

$108.03

0.86 (0.80%)

IMMVF

ImmunoVaccine

$0.00

(0.00%)

VBLT

VBL Therapeutics

$2.15

-0.075 (-3.37%)

APVO

Aptevo Therapeutics

$4.34

-0.12 (-2.69%)

SYBX

Synlogic

$11.93

0.58 (5.11%)

NKTR

Nektar

$93.81

0.31 (0.33%)

LIFE

aTyr Pharma

$2.60

-0.15 (-5.45%)

SNDX

Syndax

$11.50

0.71 (6.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 20

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 08

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 28

    May

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 23

    Oct

  • 19

    Apr

ITUS

ITUS

$4.36

-0.17 (-3.75%)

, RCUS

Arcus Biosciences

$16.67

1.22 (7.90%)

04:55
04/17/18
04/17
04:55
04/17/18
04:55
Conference/Events
American Association for Cancer Research to hold annual meeting »

AACR Annual Meeting 2018…

ITUS

ITUS

$4.36

-0.17 (-3.75%)

RCUS

Arcus Biosciences

$16.67

1.22 (7.90%)

FATE

Fate Therapeutics

$11.17

-0.38 (-3.29%)

CRSP

Crispr Therapeutics

$51.02

-0.79 (-1.52%)

ABBV

AbbVie

$92.58

0.78 (0.85%)

ADAP

Adaptimmune

$12.36

-0.11 (-0.88%)

AMGN

Amgen

$171.37

-0.06 (-0.04%)

AZN

AstraZeneca

$35.75

-0.585 (-1.61%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$54.08

-4.56 (-7.78%)

CYAD

Celyad

$31.50

0.37 (1.19%)

ECYT

Endocyte

$9.24

-0.285 (-2.99%)

MRK

Merck

$58.66

1.48 (2.59%)

AGLE

Aeglea BioTherapeutics

$9.05

-0.55 (-5.73%)

SYRS

Syros Pharmaceuticals

$13.15

-0.16 (-1.20%)

CRL

Charles River

$107.17

0.98 (0.92%)

IMMVF

ImmunoVaccine

$0.00

(0.00%)

VBLT

VBL Therapeutics

$2.23

-0.175 (-7.29%)

APVO

Aptevo Therapeutics

$4.46

0.71 (18.93%)

SYBX

Synlogic

$11.35

-0.12 (-1.05%)

NKTR

Nektar

$93.50

-6.98 (-6.95%)

LIFE

aTyr Pharma

$2.75

(0.00%)

SNDX

Syndax

$10.79

-0.64 (-5.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 17

    Apr

  • 19

    Apr

  • 20

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 08

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 28

    May

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 23

    Oct

ITUS

ITUS

$4.60

0.01 (0.22%)

, RCUS

Arcus Biosciences

$15.27

0.37 (2.48%)

07:35
04/16/18
04/16
07:35
04/16/18
07:35
Conference/Events
American Association for Cancer Research to hold annual meeting »

AACR Annual Meeting 2018…

ITUS

ITUS

$4.60

0.01 (0.22%)

RCUS

Arcus Biosciences

$15.27

0.37 (2.48%)

FATE

Fate Therapeutics

$11.54

0.11 (0.96%)

CRSP

Crispr Therapeutics

$51.77

-0.79 (-1.50%)

ABBV

AbbVie

$91.83

-0.29 (-0.31%)

ADAP

Adaptimmune

$12.45

-0.02 (-0.16%)

AMGN

Amgen

$171.48

0.46 (0.27%)

AZN

AstraZeneca

$36.32

-0.04 (-0.11%)

BAYRY

Bayer

$30.39

0.03 (0.10%)

BMY

Bristol-Myers

$58.65

-0.19 (-0.32%)

CYAD

Celyad

$31.35

(0.00%)

ECYT

Endocyte

$9.52

-0.03 (-0.31%)

MRK

Merck

$57.17

0.43 (0.76%)

AGLE

Aeglea BioTherapeutics

$9.62

-0.74 (-7.14%)

SYRS

Syros Pharmaceuticals

$13.31

0.1 (0.76%)

CRL

Charles River

$106.05

0.04 (0.04%)

IMMVF

ImmunoVaccine

$1.46

0.06 (4.27%)

VBLT

VBL Therapeutics

$2.40

0.075 (3.23%)

APVO

Aptevo Therapeutics

$3.78

-0.32 (-7.80%)

SYBX

Synlogic

$11.46

-0.28 (-2.39%)

NKTR

Nektar

$100.50

-3.24 (-3.12%)

LIFE

aTyr Pharma

$2.75

0.05 (1.85%)

SNDX

Syndax

$11.42

0.26 (2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 16

    Apr

  • 17

    Apr

  • 19

    Apr

  • 20

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 30

    Apr

  • 01

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 08

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 28

    May

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 23

    Oct

ITUS

ITUS

$4.26

0.11 (2.65%)

07:02
03/27/18
03/27
07:02
03/27/18
07:02
Hot Stocks
ITUS completes prostate cancer study with Serametrix »

ITUS announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Apr

  • 04

    May

ITUS

ITUS

$4.15

-0.1 (-2.35%)

07:02
03/26/18
03/26
07:02
03/26/18
07:02
Hot Stocks
ITUS announces issuance of second key cancer detection technology patent »

ITUS announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Apr

  • 04

    May

Over a quarter ago
ITUS

ITUS

$5.05

0.27 (5.65%)

07:02
03/16/18
03/16
07:02
03/16/18
07:02
Hot Stocks
ITUS to present data from early cancer detection study at AAI meeting »

ITUS Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITUS

ITUS

$3.26

0.11 (3.49%)

07:04
03/05/18
03/05
07:04
03/05/18
07:04
Hot Stocks
ITUS forms allliance with Serametrix »

ITUS announced that ITUS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITUS

ITUS

$6.05

-0.05 (-0.82%)

07:05
01/29/18
01/29
07:05
01/29/18
07:05
Hot Stocks
ITUS presents data from early cancer detection technology »

ITUS presented positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITUS

ITUS

$2.77

0.04 (1.47%)

07:03
12/12/17
12/12
07:03
12/12/17
07:03
Syndicate
ITUS terminates at-the-market equity program »

ITUS announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.